Author: Tajima Y. Nakagawa R.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.18, Iss.4, 1999-10, pp. : 329-334
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Overview of the Clinical Pharmacokinetics of Oxcarbazepine
By Flesch G.
Clinical Drug Investigation, Vol. 24, Iss. 4, 2004-01 ,pp. :
Antitumor Activity of Polysaccharides: An Overview
Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. :
Clinical overview of the seizure risk of dalfampridine
By Haut Sheryl R. Bienen E. Jay Miller Aaron
Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. :